CNS Response Provides Poster Review of rEEG-Guided Pharmacotherapy of Dually-Diagnosed Addiction Patients at the U.S. Psychiatric and Mental Health Congress

COSTA MESA, CA--(Marketwire - November 04, 2008) - CNS Response, Inc. (OTCBB: CNSO) reported today the results of a study presented at the U.S. Psychiatric and Mental Health Congress by Mark J. Schiller, M.D., Director of Medical Affairs for CNS Response and Assistant Clinical Professor in Psychiatry at the University of California, San Francisco. The poster presentation, titled "Referenced-EEG-Guided Pharmacotherapy of Dual-Diagnosis Patients," provided an analysis of a patient-controlled case series conducted to examine the use of CNS Response rEEG® in dual-diagnosis addiction patients.